Liver diseases in the older adult

Acta Gastro-Enterologica Belgica

Volumn 73, Issue 1, 2010, Pages 1-4

  Michielsen, P ^a   Vandewoude, M ^b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Aging; Liver disease; Liver surgery; Liver transplantation; Older adults; Viral hepatitis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; HALOTHANE; INTERFERON; ISONIAZID; PARACETAMOL; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ACUTE HEPATITIS; AGING; ALCOHOL LIVER DISEASE; ANEMIA; ANTIVIRAL THERAPY; AUTOIMMUNE HEPATITIS; CHRONICITY; COGNITIVE DEFECT; CONFUSION; DEPRESSION; GERIATRIC ASSESSMENT; HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNE RESPONSE; LETHARGY; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER FUNCTION; LIVER HISTOLOGY; LIVER TOXICITY; LIVER TRANSPLANTATION; NEUTROPENIA; NONALCOHOLIC FATTY LIVER; ORGAN DONOR; PATHOPHYSIOLOGY; SHORT SURVEY; THROMBOCYTOPENIA; TOXIC HEPATITIS; TREATMENT RESPONSE; AGE; AGED; LIVER DISEASE; REVIEW;

AGE FACTORS; AGED; HUMANS; LIVER DISEASES;

EID: 77954910738     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (55)

1. LAMBERT S., VAN DEN BELD A., VAN DER LELY A. The endo crino logy of aging. Science, 1997, 278 : 418-424.
2. POPPER H. Aging and the liver. Prog. Liver. Dis., 1986, VIII : 659-683.
3. PARDA M., ROBINO G. Oxidative stress-related molecules and liver fibrosis. J. Hepatol., 2001, 35 : 297-306.
4. TAKUBO K., NAKAMURA K., IZUMIYAMA N., FURUGORI E., SAWABE M., ARAI T., ESAKI Y., MAFUNE K., KAMMORI M., FUJIWARA M., KATO M., OSHIMURA M., SASAJIMA K. Telomere shortening with aging in human liver. J. Gerontol. A. Biol. Sci. Med. Sci., 2000, 55 : 533-536.
5. PARADIS V., YOUSSEF N., DARGÈRE D., BÂ N., BONVOUST F., DESCHATRETTE J., BEDOSSA P. Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. Hum. Pathol., 2001, 32 : 327-332.
6. WYNNE H., COPE L., MUTCH E. et al. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology, 1989, 9 : 297-301.
7. CHAN C.H. The aging liver. In : TEXTER (ed). The aging gut. Masson, New York, 1983, pp. 21-26.
8. IKEDA H., TAUCHI H., SATO T. Fine structural analysis of lipofuscin in various tissues of rats of different ages. Mech. Ageing Dev., 1985, 33 : 77-93.
9. SCHMUCKER D.L. Liver function and phase I drug metabolism in the elderly : a paradox. Drugs Aging, 2001, 18 : 837-851.
10. LE COUTEUR D.G., FRASER R., COGGER V.C., MCLEAN A.J. Hepatic pseudocapillarization and atherosclerosis in ageing. Lancet, 2002, 359 : 1612-1615.
11. TIETZ N.W., SHUEY D.F., WEKSTEIN D.R. Laboratory values in fit aging individuals - sexagenariabns through centenarians. Clin. Chem., 1992, 38 : 1167-1185.
12. ABELLAN VAN KAN G., ROLLAND Y., BERGMAN H., MORLEY J.E., KRITCHEVSKY S.B., VELLAS B. The I.A.N.A Task Force on frailty assessment of older people in clinical practice. J. Nutr. Health Aging, 2008, 12 : 29-37.
13. WILLNER I.R., UHL M.D., HOWARD S.C., WILLIAMS E.Q., RIELY C.A., WATERS B. Serious hepatitis A : an analysis of patients hospitalized during an urban epidemic in the United States. Ann. Intern. Med., 1998, 128 : 111-114.
14. THIERFELDER W., MEISEL H., SCHREIER E., DORTSCHY R. Die Prävalenz von Antikörpern gegen Hepatitis A, Hepatitis B, und Hepatitis Cviren in der deutschen Bevölkerung. Gesundheitswesen, 1999, 61 : 110-114.
15. CDC. Prevention of hepatitis A through active or passive immunization : recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 1999, 48 (No RR-12) : 1-37.
16. KONDO Y., TSUKADA K., TAKEUCHI T., MITSUI T., IWANO K., MASUKO K., ITOH T., TOKITA H., OKAMOTO H., TSUDA F., MIYAKAWA Y., MAYUMI M. High carrier rate after hepatitis B virus infection in the elderly. Hepatology, 1993, 18 : 768-774.
17. CHIARAMONTE M., FLOREANI A., NACCARATO R. Hepatitis B virus (HBV) in the elderly : an underestimated problem ? Biomed. Pharmacother., 1987, 41 : 121-123.
18. DENIS F., MOUNIER M., HESSEL L., MICHEL J.P., GUALDE N., DUBOIS F., BARIN F., GOUDEAU A. Hepatitis-B vaccination in the elderly . J. Infect. Dis., 1984, 149 : 1019.
19. ROUDOT-THORAVAL F., BASTIE A., PAWLOTSKY J.M., DHUMEAUX D. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease : a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. Hepatology, 1997, 26 : 485-490.
20. POYNARD T., RATZIU V., CHARLOTTE F., GOODMAN Z., MCHUTCHISON J., ALBRECHT J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J. Hepatol., 2001, 34 : 730-739.
21. MANNS M.P., MCHUTCHISON J.G., GORDON S.C., RUSTGI V.K., SHIFFMAN M., REINDOLLAR R., GOODMAN Z.D., KOURY K., LING M., ALBRECHT J.K. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C : a randomised trial. Lancet, 2001, 358 : 958-965. (Pubitemid 32913521)
22. FRIED M.W., SHIFFMAN M.L., REDDY K.R., SMITH C., MARINOS G., GONÇALES F.L. JR, HÄUSSINGER D., DIAGO M., CAROSI G., DHUMEAUX D., CRAXI A., LIN A., HOFFMAN J., YU J. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med., 2002, 347 : 975-982.
23. FLOREANI A., MINOLA E., CARDERI I., FERRARA F., ROSA RIZZOTTO E., BALDO V. Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C ? J. Am. Geriatr. Soc., 2006, 54 : 549-550.
24. NUDO C.G., WONG P., HILZENRAT N., DESCHÊNES M. Elderly patients are at greater risk of cytopenia during antiviral therapy for hepatitis C. Can. J. Gastroenterol., 2006, 20 : 589-592.
25. MARCUS E.L., TUR-KASPA R. Viral hepatitis in older adults. J. Am. Geriat.r Soc., 1997, 45 : 755-763.
26. MICHIELSEN P., BRENARD R., BOURGEOIS N., DE GALOCSY C.H., DELWAIDE J., HENRION J., HORSMANS Y., NEVENS F., REYNAERT H., ROBAEYS G., SPRENGERS D., VAN VLIERBERGHE H. Steering Committee Belgian Association for the Study of the Liver.Hepatitis C : screening, treatment and prevention practical guidelines. Acta Gastroenterol. Belg., 2003, 66 : 15-19.
27. Asian Pacific Association for the Study of the Liver (APASL) Hepatitis C Working Party, MCCAUGHAN G.W., OMATA M., AMARAPURKAR D., BOWDEN S., CHOW W.C., CHUTAPUTTI A., DORE G., GANE E., GUAN R., HAMID S.S., HARDIKAR W., HUI C.K., JAFRI W., JIA J.D., LAI M.Y, WEI L., LEUNG N., PIRATVISUTH T., SARIN S., SOLLANO J., TATEISHI R. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection. J. Gastroenterol. Hepatol., 2007, 22 : 615-633.
28. GHANY M.G., STRADER D.B., THOMAS D.L., SEEFF L.B. AASLD Practice Guidelines. Diagnosis, management and treatment of hepatitis C : an update. Hepatology, 2009, 49 : 1335-1374.
29. JANSEN P. Liver disease in the elderly. Best Pract. Res Clin. Gastroenterol., 2002, 16 : 149-158.
30. NEUBERGER J., WILLIAMS R. Halothane anaesthesia and liver damage. B. Med. J., 1984, 289 : 136-1139.
31. LARREY D., CHAPOUTOT C. Les hépatites et les atteintes des voies biliaires dues à l'amoxicilline-acide clavulanique. Hepato-Gastro, 1998, 5 : 45-52.
32. MADDREY W.C. Isoniazid-induced liver disease. Semin Liver Dis., 1981 ; 1 : 77-84.
33. WYNNE H., COPPE L., HERD B. The association of age and frailty with paracetamol conjugation in man. Age and Ageing, 1990, 19 : 419-424.
34. ADAMS W.L., COX N.S. Epidemiology of problem drinking among elderly people. Int. J. Addict., 1995, 30 : 1693-1716.
35. GARAGLIANO C.F., LILIENFELD A.M., MENDELOFF A.J. Incidence rates of liver cirrhosis and related diseases in Baltimore and selected areas of the United States. J. Chronic. Dis., 1979, 32 : 543-554.
36. POTTER J.F., JAMES O.F. Clinical features and prognosis of alcoholic liver disease in respect of advancing age. Gerontology, 1987, 33 : 380-387.
37. ANGULO P., KEACH J.C., BATTS K.P., LINDOR K.D. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology, 1999, 30 : 1356-1362.
38. NEUSCHWANDER-TETRI B.A., CALDWELL S.H. Non-alcoholic steatohepatitis : summary of an AASLD single topic conference. Hepatology, 2003, 38 : 420-427.
39. SCHRAMM C., KANZLER S., MEYER ZUM BUSCHENFELDE K.H., GALLE P.R., LOHSE A.W. Auto-immune hepatitis in the elderly. Am. J. Gastroenterol., 2001, 96 : 1587-1591.
40. VERSLYPE C., GEORGE C., BÜCHEL E., NEVENS F., VAN STEENBERGEN W., FEVERY J. Diagnosis and treatment of autoimmune hepatitis at age 65 and older. Aliment Pharmacol. Ther., 2005, 21 : 695-699.
41. AL-CHALABI T., BOCCATO S., PORTMANN B.C., MCFARLANE I.G., HENEGHAN M.A. Autoimmune hepatitis (AIH) in the elderly : a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed in a tertiary referral centre. J. Hepatol., 2006, 46 : 575-583.
42. DEL OLMO J.A., SERRA M.A., RODRIGUEZ F., ESCUDERO A., GILABERT S., RODRIGO J.M. Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis. J. Cancer Res. Clin. Oncol., 1998, 124 : 560-564.
43. MURAKAMI C., HINO K., KORENAGA M., OKAZAKI M., OKUDA M., NUKUI K., OKITA K. Factors predicting progression to cirrhosis and hepatocellular carcinoma in patients with transfusion-associated hepatitis C virus infection. J. Clin. Gastroenterol., 1999, 28 : 148-152.
44. COLLIER J.D., CURLESS R., BASSENDINE M.F., JAMES O.F. Clinical features and prognosis of hepatocellular carcinoma in Britain in relation to age. Age Ageing, 1994, 23 : 22-27.
45. ETTORRE G.M., SOMMACALE D., FARGES O., SAUVANET A., GUEVARA O., BELGHITI J. Postoperative liver function after elective right hepatectomy in elderly patients. Br. J. Surg., 2001, 88 : 73-76.
46. YANAGA K., KANEMATSU T., MATSUMATA T., YOSHIDA Y., SUGIMACHI K. Hepatic resection for hepatocellular carcinoma in elderly patients. Am. J. Surg., 1988, 155 : 238-241.
47. POON R.T., FAN S.T., LO C.M., LIU C.L., NGAN H., NG I.O., WONG J. Hepatocellular carcinoma in the elderly : results of surgical and nonsurgical management. Am. J. Gastroenterol., 1999, 194 : 2460-2466.
48. BISMUTH H. Hepatocellular carcinoma in the elderly : results of surgical and nonsurgical management. Am. J. Gastroenterol., 1999, 94 : 2336-2337.
49. EL-SERAG H., SIEGEL A., DAVILA J., SHAIB Y.H., CAYTON-WOODY M., MCBRIDE R., MCGLYNN K.A. Treatment and outcomes of treatment of hepatocellular carcinoma among Medicare recipients in the United States : a population based study. J. Hepatol., 2006, 44 : 158-166.
50. COLLINS B., PIRSCH J., BECKER Y., HANAWAY M.J., VAN DER WERF W.J., D'ALESSANDRO A.M., KNECHTLE S.J., ODORICO J.S., LEVERSON G., MUSAT A., ARMBRUST M., BECKER B.N., SOLLINGER H.W., KALAYOGLU M. Long-term results of liver trans - plantation in patients 60 years of age and older. Transplantation, 2000, 70 : 780-783.
51. FENG S., ROBERTS J. An older liver in the hand or a (possibly) younger liver in the bush ? Am. J. Transpl., 2005, 5 : 425-427.
52. BERENGUER M., PRIETO M., SAN JUAN F., RAYON J., MARTINEZ F., CARRASCO D., MOYA A., ORBIS F., MIR J., BERENGUER J. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology, 2002, 36 : 202-210.
53. BERENGUER M. Recurrent allograft disease : viral hepatitis. Acta Gastroenterol. Belg., 2005, 68 : 337-346.
54. WALI M., HARRISON R., GOW P., MUTIMER D. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut, 2002, 51 : 248-252.
55. MACHICAOV, BONATTI H., KRISHNA M., AQUEL B., LUKENS F., NGUYEN J., ROSSER B., SATYANARAYANA R., GREWAL H., HEWITT W., HARNOIS D., CROOK J., STEERS J., DICKSON R. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation, 2004, 77 : 84-92.